First patient receives controversial Biogen Alzheimer's drug

Published June 18, 2021 27 Views $0.01 earned

Rumble A U.S. hospital on Wednesday gave the first infusion of an expensive, controversial new Alzheimer's drug from Biogen. Flora Bradley-Watson reports.